CIHR Operating Grant: Addressing the Wider Health Impacts of COVID-19
Launched in early September, this funding opportunity seeks research proposals to address the gaps in knowledge about the wider impacts of the COVID-19 pandemic and response on the health and health care of people in Canada. Suspension/interruption of cancer screening is one of the research areas of focus.
The maximum amount per grant that can be requested for clinical trial research is $1,000,000 over 2 years; for other types of research, the maximum amount per grant is $500,000 over 2 years. Registration deadline is October 18, 2021. For more information, see https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=3548&language=E.
Innovating Against Cancer
The Canadian Partnership Against Cancer is working with partners across Canada to accelerate and introduce programs that will restore and sustain cancer care. Learn more. Read More »
The Canadian Partnership Against Cancer is working with partners across Canada to accelerate and introduce programs that will restore and sustain cancer care. Learn more. Read More »
New Member to the CCRA Board
CCRA welcomes Dr. Dajan O’Donnell to its Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a PhD in neur... Read More »
CCRA welcomes Dr. Dajan O’Donnell to its Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a PhD in neur... Read More »